The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CLDX FINANCIAL STATEMENTS

Celldex Therapeutics Inc — balance sheet, income statement and cash flow trends

CLDXCelldex Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-300 M-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue112 K $Gross Profit-63.7 M $ · -56871%Operating Income-245.2 M $ · -218963%Pre-tax Income-300.6 M $ · -268386%Net Income to Owners-300.6 M $ · -268386%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue112 K $-98.1%
Gross Profit-63.7 M $—
Operating Income-245.2 M $—
EBITDA-224.6 M $—
Net Income to Owners-300.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets782.3 M
  • Equity714.6 M $91%
  • Current Liabilities61.3 M $8%
  • Long-term Liabilities6.5 M $1%

Key Figures

YoY change
Total Assets782.3 M $+13.0%
Total Liabilities67.8 M $+83.2%
Total Equity714.6 M $+9.0%
Cash & ST Investments717.6 M $+13.8%
Total Debt4.9 M $+61.8%
Net Debt-42.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-300 M-200 M-100 M0-301.2 M $Operating5 M $Investing327.4 M $Financing31.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-301.2 M $—
Capital Expenditures7.9 M $+233.3%
Free Cash Flow-309 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CLDX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.